Market in sight for Pharmaxis
20 August, 2008 by Dylan Bushell-EmblingPharmaxis concludes Phase 3 trial of Bronchitol
Happy as a pig
20 August, 2008 by Dylan Bushell-EmblingImugene reports early PRRS vaccine trial results
Anadis fights flu
20 August, 2008 by Dylan Bushell-EmblingAnadis shows proof-of-principle for spray-based 'flu fighter'
Aldridge quits Peplin
19 August, 2008 by Dylan Bushell-EmblingPeplin appoints new CEO and president/CMO
$3 million for Chagas research
15 August, 2008 by Kate McDonaldMurdoch University and Epichem get $3 million Chagas research boost
Genentech rejects Roche bid
15 August, 2008 by Kate McDonaldUS biotech Genentech rejects $43.7 billion takeover deal
Acrux-Organon partnership dropped
15 August, 2008 by Dylan Bushell-EmblingSchering-Plough cancels two projects with Acrux
Life's Full Court appeal accepted
15 August, 2008 by Dylan Bushell-EmblingLife's legal battle with Bell IXL will continue, after the Full Court ordered a retrial.
Acrux heads to the Finnish
14 August, 2008 by Dylan Bushell-EmblingAcrux signs exclusive manufacturing partner for Testosterone MD-Lotion
Circadian owns Vegenics
14 August, 2008 by Dylan Bushell-EmblingCircadian finalises Vegenics purchase
Biotron expands HCV trial
14 August, 2008 by Dylan Bushell-EmblingBiotron adds Brisbane site for hep C clinical trial
Bioprocessing conference
13 August, 2008 by External Press Release AuthorAustralia's BioProcessing Network conference being held in October
CSL profit up 30pc, to outlay $3.5b for Talecris
13 August, 2008 by Kate McDonaldCSL reports massive earnings, agrees to buy US plasma business Talecris
